Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...

President-elect Donald Trump has tapped Dr Jay Bhattacharya, a Stanford health economist, to lead the National Institutes of Health.

To run the US Centers for Disease Control and Prevention, Trump has turned to David Weldon, MD, a long-time internist who interrupted his medical career to represent a Florida district for 7 terms in ...

Adding pembrolizumab to radiotherapy and surgery can improve disease-free survival in patients with certain types of sarcoma.

Imkeldi is supplied as a strawberry-flavored oral solution in a 140 mL, child-resistant, tamper-evident bottle.

"In a country with the wealth and resources of the USA, it is intolerable that so many are living in conditions and with health outcomes akin to those of an entirely different country," the ...

Clinical factors associated with an increased risk of psychological distress included younger age, female sex, advanced pathological/tumor stage, and preoperative setting.

The combination of chemotherapy and radioembolization appeared safe and effective in patients with well-differentiated, liver-dominant, grade 3 NETs.

The approval is supported by data from the COBLT study, FDA dockets and public information, and an observational database.

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

NP-101 plus nivolumab and ipilimumab demonstrated activity in patients with metastatic EP-NECs that were refractory to chemotherapy.

In its accelerated approval decisions of new cancer drugs, the FDA might be underestimating the willingness of some patients ...